J Korean Med Sci.  2022 Jul;37(29):e231. 10.3346/jkms.2022.37.e231.

Association of Depression With Susceptibility and Adaptation to Seasickness in the Military Seafarers

Affiliations
  • 1Department of Neurology, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea
  • 2Department of Neurology, Chung-Ang University Hospital, Seoul, Korea
  • 3Department of Neurology, El Hospital, Namyangju, Korea
  • 4Department of Neurology, Incheon St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Incheon, Korea
  • 5Department of Neurology, Anyang SAM Hospital, Anyang, Korea
  • 6Department of Physical Therapy, Yonsei University, Wonju, Korea

Abstract

Background
Although depression and motion sickness are prevalent in military personnel and seafarers, the association between depression and seasickness has been not yet elucidated. We aimed to evaluate the relationship of depression with initial susceptibility and adaptation to seasickness amongst military seafarers.
Methods
This retrospective cohort enrolled Navy seafarers who started seafaring between 2017 and 2019. Three groups were established according to the Beck Depression Inventory (BDI) score: no depression (BDI score of 0), minimal depression (BDI score 1–9), and mild-tomoderate depression (BDI score 10–29). The occurrence of seasickness requiring treatment was observed as the prescription of medication for the first 30 distant seafaring days. Considering adjustment period, the two different outcomes were defined. The susceptibility to seasickness was evaluated via at least one day suffered from seasickness requiring treatment during the early period (the first 5 seafaring days), and adaptation ability to seasickness was defined by more than 10% of the ratio, calculated days suffered from seasickness requiring treatment/days of seafaring during the late period (the 6–30th seafaring days). Binary logistic regression was further evaluated to estimate the odds of BDI groups and BDI score adjusted for age and workplace whether outside visual perception was possible.
Results
Among the 185 recruits, 179 participants (97%) sailed for more than 5 days were included in the study. Of the participants, 36% was susceptible to seasickness in the early and 17% was poorly adapted to seasickness in the late period. Multivariable model revealed that mild-to-moderate depression had elevated risk of poor adaptation (odds ratio [OR], 4.63; 95% confidence interval [CI], 1.31–16.98) whereas the results were not statistically significant for susceptibility to seasickness in the early period BDI score was independently associated with increased odds of poor adaptation (OR, 1.10; 95% CI, 1.04–1.18).
Conclusion
The present study suggests that depression is associated with poor adaptation to seasickness in Navy seafarers. Depression screening tool might be helpful for providing preventable strategies for population at risk.

Keyword

Motion Sickness; Depression; Mass Screening

Figure

  • Fig. 1 The occurrence of seasickness requiring treatment among the participants according to days of seafaring.


Reference

1. Ministry of National Defense (KR). 2012 Defense White Paper. Seoul, Korea: Defense Policy Division, Policy Planning Bureau;2012.
2. Byeon G, Jo SJ, Lee HW, Yim HW, Park JI. Development of a short form depression screening questionnaire for Korean soldiers. J Korean Med Sci. 2021; 36(27):e185. PMID: 34254472.
Article
3. Shin YC, Kim SM, Kim H, Min KJ, Yoo SK, Kim EJ, et al. Resilience as a protective factor for depressive mood and anxiety among Korean employees. J Korean Med Sci. 2019; 34(27):e188. PMID: 31293112.
Article
4. Oldenburg M, Baur X, Schlaich C. Occupational risks and challenges of seafaring. J Occup Health. 2010; 52(5):249–256. PMID: 20661002.
Article
5. Jezewska M, Leszczyńska I, Jaremin B. Work-related stress at sea self estimation by maritime students and officers. Int Marit Health. 2006; 57(1-4):66–75. PMID: 17312695.
6. Lefkowitz RY, Slade MD. Seafarer mental health study: final report, October 2019. Updated 2019. Accessed May 15, 2022. https://seafarerstrust.org/sites/default/files/node/publications/files/ST_MentalHealthReport_Final_Digital-1.pdf .
7. Iversen RT. The mental health of seafarers. Int Marit Health. 2012; 63(2):78–89. PMID: 22972547.
8. Lucas D, Mehaneze M, Loddé B, Jegaden D. Seasickness and its impact on researchers’ work on board French oceanographic vessels. Int Marit Health. 2020; 71(3):160–165. PMID: 33001426.
Article
9. Carotenuto A, Molino I, Fasanaro AM, Amenta F. Psychological stress in seafarers: a review. Int Marit Health. 2012; 63(4):188–194. PMID: 24595974.
10. Allen P, Wadsworth E, Smith A. Seafarers’ fatigue: a review of the recent literature. Int Marit Health. 2008; 59(1-4):81–92. PMID: 19227741.
11. Williams RA, Hagerty BM, Yousha SM, Hoyle KS, Oe H. Factors associated with depression in navy recruits. J Clin Psychol. 2002; 58(4):323–337. PMID: 11920688.
Article
12. Benson AJ, Barnes GR. Vision during angular oscillation: the dynamic interaction of visual and vestibular mechanisms. Aviat Space Environ Med. 1978; 49(1 Pt. 2):340–345. PMID: 304721.
13. Schmäl F. Neuronal mechanisms and the treatment of motion sickness. Pharmacology. 2013; 91(3-4):229–241. PMID: 23615033.
Article
14. Hong S, Kim S, Park DH, Ryu SH, Ha JH, Jeon HJ. The mediating effect of insomnia on the relationship between panic symptoms and depression in patients with panic disorder. J Korean Med Sci. 2021; 36(9):e30. PMID: 33686808.
Article
15. Altunayoglu Cakmak V, Gazioglu S, Can Usta N, Ozkorumak E, Ayar A, Topbas M, et al. Evaluation of temperament and character features as risk factors for depressive symptoms in patients with restless legs syndrome. J Clin Neurol. 2014; 10(4):320–327. PMID: 25324881.
Article
16. Hwang KJ, Kim EH, Kim YJ, Hong SB. Frequency of depression and suicidality in patients with neurological disorders: epilepsy, Parkinson’s disease, and ischemic stroke. J Korean Neurol Assoc. 2016; 34(3):193–200.
Article
17. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4(6):561–571. PMID: 13688369.
Article
18. Beck AT, Steer RA, Garbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988; 8(1):77–100.
Article
19. Zhang X, Sun Y. Motion sickness predictors in college students and their first experience sailing at sea. Aerosp Med Hum Perform. 2020; 91(2):71–78. PMID: 31980044.
Article
20. Alcantara-Thome M, Miguel-Puga JA, Jauregui-Renaud K. Anxiety and motion sickness susceptibility may influence the ability to update orientation in the horizontal plane of healthy subjects. Front Integr Neurosci. 2021; 15:742100. PMID: 34594190.
Article
21. Reason JT. Relations between motion sickness susceptibility, the spiral after-effect and loudness estimation. Br J Psychol. 1968; 59(4):385–393. PMID: 5719793.
Article
22. Lackner JR. Motion sickness: more than nausea and vomiting. Exp Brain Res. 2014; 232(8):2493–2510. PMID: 24961738.
Article
23. Leung AK, Hon KL. Motion sickness: an overview. Drugs Context. 2019; 8:2019-9-4.
Article
24. Zhang LL, Wang JQ, Qi RR, Pan LL, Li M, Cai YL. Motion sickness: current knowledge and recent advance. CNS Neurosci Ther. 2016; 22(1):15–24. PMID: 26452639.
Article
25. Liu W, Ge T, Leng Y, Pan Z, Fan J, Yang W, et al. The role of neural plasticity in depression: from hippocampus to prefrontal cortex. Neural Plast. 2017; 2017:6871089. PMID: 28246558.
Article
26. Bigelow RT, Semenov YR, du Lac S, Hoffman HJ, Agrawal Y. Vestibular vertigo and comorbid cognitive and psychiatric impairment: the 2008 National Health Interview Survey. J Neurol Neurosurg Psychiatry. 2016; 87(4):367–372. PMID: 25886779.
Article
27. Meltzer H. Serotonergic dysfunction in depression. Br J Psychiatry Suppl. 1989; 155(8):25–31.
Article
28. Kapur S, Mann JJ. Role of the dopaminergic system in depression. Biol Psychiatry. 1992; 32(1):1–17. PMID: 1391289.
Article
29. Nutt DJ. Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry. 2008; 69 (Suppl E1):4–7.
30. Drummond PD. Effect of tryptophan depletion on symptoms of motion sickness in migraineurs. Neurology. 2005; 65(4):620–622. PMID: 16116130.
Article
31. Spinks AB, Wasiak J, Villanueva EV, Bernath V. Scopolamine for preventing and treating motion sickness. Cochrane Database Syst Rev. 2004; (3):CD002851. PMID: 15266468.
Article
32. Held R. Exposure-history as a factor in maintaining stability of perception and coordination. J Nerv Ment Dis. 1961; 132(1):26–32. PMID: 13713070.
Article
33. Ruckenstein MJ, Harrison RV. Motion sickness. Helping patients tolerate the ups and downs. Postgrad Med. 1991; 89(6):139–144.
34. Helling K, Westhofen M. Experimental studies of motion sickness on board of a research ship. HNO. 1994; 42(4):214–219. PMID: 8021156.
35. Cha JM, Kim JE, Kim MA, Shim B, Cha MJ, Lee JJ, et al. Five months follow-up study of school-based crisis intervention for Korean high school students who experienced a peer suicide. J Korean Med Sci. 2018; 33(28):e192. PMID: 29983694.
Article
36. Lim AY, Lee SH, Jeon Y, Yoo R, Jung HY. Job-seeking stress, mental health problems, and the role of perceived social support in university graduates in Korea. J Korean Med Sci. 2018; 33(19):e149. PMID: 29736162.
Article
37. Sohn BK, Park SM, Park IJ, Hwang JY, Choi JS, Lee JY, et al. The relationship between emotional labor and job stress among hospital workers. J Korean Med Sci. 2018; 33(39):e246. PMID: 30250411.
Article
38. Woo SY, Kim HJ, Kim BR, Ahn HC, Jang BN, Park EC. Support from superiors reduces depression in Republic of Korea military officers. BMJ Mil Health. 2021; 167(6):378–382.
Article
39. Chan G, Moochhala SM, Zhao B, Wl Y, Wong J. A comparison of motion sickness prevalence between seafarers and non-seafarers onboard naval platforms. Int Marit Health. 2006; 57(1-4):56–65. PMID: 17312694.
Full Text Links
  • JKMS
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr